Should I Buy Regulus Therapeutics Inc (RGLS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Regulus Therapeutics Inc. (RGLS)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,376,207 | $4,558 | +5% | 0.17% |
| 2. | Point72 Asset Management Steve Cohen | 3,215,436 | $4,292 | 0.02% | |
| 3. | Sarissa Capital Management Alex Denner | 1,851,851 | $2,499 | 0.25% | |
| 4. | Renaissance Technologies Jim Simons | 449,200 | $606 | 0% | |
| 5. | Bourgeon Capital John Zaro | 317 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.62 | 4,398,602 | Large Shareholder | 6,451,056 | 2020-12-04 | Filing | |
| $0.62 | 4,398,602 | Large Shareholder | 6,451,056 | 2020-12-04 | Filing | |
| $0.62 | 4,398,602 | Large Shareholder | 6,451,056 | 2020-12-04 | Filing | |
| $0.62 | 4,398,602 | Large Shareholder | 6,451,056 | 2020-12-04 | Filing | |
| $0.62 | 4,398,602 | Large Shareholder | 6,451,056 | 2020-12-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 828 | Officer | 42,614 | 2021-02-16 | Filing | |
| $1.72 | 4,144 | Officer, Director | 485,756 | 2021-02-16 | Filing | |
| $0.52 | 876 | Officer | 25,762 | 2020-11-16 | Filing | |
| $0.52 | 6,094 | Officer, Director | 215,994 | 2020-11-16 | Filing | |
| $0.60 | 4,245 | Officer, Director | 222,088 | 2020-08-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 6,451,056 | $8,709 | 0.22% | |
| 2. | 1,607,720 | $2,170 | 0.4% | |
| 3. | 499,989 | $675 | 0% | |
| 4. | 386,659 | $522 | 0% | |
| 5. | 120,986 | $163 | 0% |
News See All
Hedge Funds Are Dumping Regulus Therapeutics Inc (RGLS)
How do we determine whether Regulus Therapeutics Inc (NASDAQ:RGLS) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend...
13G Filing: Broadfin Capital and Regulus Therapeutics Inc. (RGLS)
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...
Insider Buying at Regulus Therapeutics Inc (RGLS) Sends Stock Soaring
Regulus Therapeutics Inc (NASDAQ:RGLS) shares have jumped $0.30 per share, or 24%, to $1.55 in after hours on Thursday. Traders have bid up shares due to the company disclosing in a regulatory filing...
How Regulus Therapeutics Inc (RGLS) Stacks Up Against Its Peers
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
Why Are These Stocks Deep in Red Today?
Among the losers today are Regulus Therapeutics Inc (NASDAQ:RGLS), Vista Gold Corp. (NYSEMKT:VGZ), Babcock & Wilcox Enterprises Inc (NYSE:BW), Barrick Gold Corporation (USA) (NYSE:ABX), and COMSCORE...
What’s Going On With These 5 Trending Stocks?
U.S stocks are trading down ever so slightly on this fine Friday afternoon. Even though oil prices are plummeting ahead of the Doha oil producers' meeting this weekend, better-than-feared financial results...
Billionaire Hedge Funds
